EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome

Blanka Stiburkova iD, Katerina Pavelcova, Monika Belickova iD, Samuel J Magaziner iD, Jason C Collins, Achim Werner, David B Beck, Veronika Balajkova, Cyril Salek iD, Martin Vostry, Herman Mann, Jiri Vencovsky

Arthritis & Rheumatology · 2023

DOI: 10.1002/art.42471 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Arthritis & Rheumatology, 2023. Verfasst von Blanka Stiburkova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Rheumatology, Department of Rheumatology, and Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Cha…. Hauptthemen laut MEDLINE: Ubiquitin-Activating Enzymes, Myelodysplastic Syndromes. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, RVO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Somatic mutations in UBA1 have recently been causally linked to a severe adult‐onset inflammatory condition referred to as VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Ubiquitin‐activating enzyme E1 (UBA‐1) is of fundamental importance to the modulation of ubiquitin homeostasis and to the majority of downstream ubiquitylation‐dependent cellular processes. Direct sequencing analysis of exon 3 containing the prevalent variants p.Met41Leu, p.Met41Val, and/or p.Met41Thr is usually used to confirm the disease‐associated mutations.

Methods

We studied the clinical, biochemical, and molecular genetic characteristics of a 59‐year‐old man with a 2‐year history of arthritis, fever, night sweats, nonspecific skin rash, lymphadenopathy, and myelodysplastic syndrome with multilineage dysplasia.

Results

The mutational analysis revealed a previously undescribed sequence variant c.1430G>C in exon 14 (p.Gly477Ala) in the gene UBA1 . In vitro enzymatic analyses showed that p.Gly477Ala led to both decreased E1 ubiquitin thioester formation and E2 enzyme charging.

Conclusion

We report a case of a patient of European ancestry with clinical manifestations of VEXAS syndrome associated with a newly identified dysfunctional UBA‐1 enzyme variant. Due to the patient's insufficient response to various immunosuppressive treatments, allogeneic hematopoietic stem cell transplantation was performed, which resulted in significant improvement of clinical and laboratory manifestations of the disease. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Activating EnzymesMyelodysplastic SyndromesMaleMutationHumansPatientsUbiquitinsMiddle AgedAdultSkin Diseases, Genetic

Substanzen

Ubiquitin-Activating EnzymesUbiquitins

Autor:innen und Institutionen

  • Institute of Rheumatology, Department of Rheumatology, and Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republi…
  • Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Center for Human Genetics and Genomics, New York University School of Medicine, New York.
  • National Institute for Dental and Craniofacial Research, NIH, Bethesda, Maryland.
  • Center for Human Genetics and Genomics, and Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York.

ORCID-Profile: Blanka Stiburkova, Monika Belickova, Samuel J Magaziner, Cyril Salek

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • RVO
  • National Institutes of Health
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Stiburkova, B., Pavelcova, K., Belickova, M., Magaziner, S. J., Collins, J. C., Werner, A., Beck, D. B., Balajkova, V., Salek, C., Vostry, M., Mann, H., & Vencovsky, J. (2023). Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome. Arthritis & Rheumatology. https://doi.org/10.1002/art.42471

Vancouver

Stiburkova B, Pavelcova K, Belickova M, Magaziner SJ, Collins JC, Werner A, et al. Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome. Arthritis & Rheumatology. 2023. doi:10.1002/art.42471

BibTeX
@article{Stiburkova2023,
  author = {Stiburkova, Blanka and Pavelcova, Katerina and Belickova, Monika and Magaziner, Samuel J and Collins, Jason C and Werner, Achim and Beck, David B and Balajkova, Veronika and Salek, Cyril and Vostry, Martin and Mann, Herman and Vencovsky, Jiri},
  title = {Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome},
  journal = {Arthritis & Rheumatology},
  year = {2023},
  doi = {10.1002/art.42471}
}
Kostenlos starten →